The road to discovery and innovation can be long and tough.
Let us iron out the bends.
Because we can.
PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene's patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical translational research and biomarker development.
- research groups to discover new drug targets, optimise lead compounds and understand the mechanism of action of these compounds using cell line models.
- toxicology groups with mechanistic tox studies and classical tox studies in an attempt to replace certain animal testing
- translational biomarker groups in their goal to deliver leads and relevant PD and classification biomarkers to the clinic
- patient classification for clinical trials.
Through information provided on our website, we hope you will discover the added value of PamGene's approach, the extensive application possibilities and our broad network of collaborators. We will gladly answer all your questions!